The study of DNA damage in exfoliated buccal cells is a minimally invasive method for monitoring populations for exposure to genotoxic agents. The presence of micronuclei (MN) and other nuclear anomalies within these cells has been shown to be associated with genetic defects in genome maintenance, accelerated ageing, genotoxic damage and some degenerative diseases. To identify important information gaps regarding these biomarkers, a new initiative was launched within the framework of the HUman MicroNucleus (HUMN) collaborative programme, the HUMN XL project ('XL' designating eXfoLiated cell). An invitation to join the project was sent out together with a questionnaire to all laboratories that have published on the buccal micronucleus assay. Overall, 188 messages were delivered and 58 laboratories from 25 countries agreed to participate (43 contributing data). The questionnaire was designed to collect methodological information regarding the laboratory's performance of the assay and to assess the extent and type of epidemiological data that are routinely collected. The results provide an overview of the most commonly used methods for buccal cell collection and preparation, slide preparation, staining, scoring criteria and an evaluation of epidemiological data, including demographics, genetic background, gender, health status, occupation, exposure, lifestyle and dietary habit. According to this survey, a potential base of 15 103 subjects can be included in future pooled analyses. A number of protocol discrepancies emerged, implying that method standardization is a major priority. The results of this survey will contribute to (i) identify technical and epidemiological key variables that impact on buccal MN frequency in human populations, (ii) drive the design of future intra-and interlaboratory validation studies and (iii) determine the role of MN frequency and other biomarkers, in monitoring genomic damage and predicting cancer and other degenerative diseases.
Introduction
The study of DNA damage in exfoliated cells collected from the oral cavity holds great promise as a minimally invasive method for monitoring populations exposed to genotoxic agents. The presence of micronuclei (MN) and other nuclear anomalies within these cells has been shown to be associated with genetic defects in genome maintenance, accelerated ageing, exposure to genotoxic agents, oral cancer risk and neurodegenerative diseases and was also used in chemopreventive studies (1) . While these results indicate the suitability of this assay for measuring chromosomal damage in human populations, the mechanism linking MN in buccal exfoliated cells to chromosome damage in progenitor cells is difficult to prove given the difficulty in performing chromosome metaphase analysis in this cell type. However, given the extensive evidence from in vitro studies of cultured epithelial cells and lymphocytes demonstrating that MN originate from either lagging chromosome fragments or whole chromosomes, it is reasonable to infer that MN in buccal cells originate mainly via these mechanisms.
In May 2007, the HUman MicroNucleus (HUMN) project held its eighth workshop in Antalya, Turkey, to seek the opinions of experts in the field on the current status of the method, focusing on its strengths and limitations and need for improvement (2) . As a consequence of the workshop, the steering committee of the HUMN project completed an extensive review of existing work in this field (1), proposed a protocol for the so-called 'cytome assay' in the exfoliated buccal cells (3) and launched a new initiative to identify important knowledge and information gaps regarding the detection and characterization of nuclear anomalies in buccal cells. To distinguish between the exfoliated buccal micronucleus assay programme and the HUMN lymphocytes project, a new acronym was proposed for the new initiative, i.e. HUMN XL project ('XL' designating eXfoLiated cell).
During the workshop held in Antalya, it was decided that the first step of the programme would be to perform a detailed survey of the current methodological and data acquisition status of laboratories that have published papers on the buccal MN assay. The results of this survey are discussed here, together with the basic elements of a research programme aimed at (i) developing and testing a standardized improved protocol and (ii) validating the buccal cell micronucleus test as a non-invasive biomarker of genome damage and disease risk.
case, we performed a free-text search in the title or abstract field, using the terms 'Micronucleus test' and 'buccal cells', and (iii) by personal communication.
An 
Questionnaire
The present questionnaire was developed from the version previously validated for the lymphocyte project (4) and was designed to obtain the following data:
General information about the experience of the laboratory with the buccal MN assay, including the number of subjects studied. Detailed information relating to study subjects' background information, including demographics, genetic constitution, gender, health status, occupation, potential genotoxic exposure, lifestyle and diet. List of publications from the laboratory using the buccal MN assay. Details of the method used for the collection of buccal cells including specification from which part of the mouth the cells were collected. Details of the method used for cell washing, fixation and slide preparation prior to staining. Description of the staining method used. Description of the scoring method and criteria indicating which of the previously published methods were used, if any. Specification of methods for data collection, including biomarkers scored for DNA damage, cell proliferation and cell death and the number of cells scored.
A copy of the questionnaire for those interested in contributing their data to the project database is available on the HUMN project website (www.HUM-N.org).
Statistical analysis of questionnaire data
Data from each questionnaire were entered into a MicrosoftÒ Access database developed ad hoc for this survey. Statistical analysis and graphical elaborations were performed with the statistical software SPSS Release 15.0 (SPSS, Chicago, IL).
Results

Participants
The questionnaire was completed by scientists from 58 laboratories from 54 different research institutions in 25 different countries representing all continents except Africa. Only 43 (74.1%) of these laboratories stated that they had data resulting from the use of the buccal MN assay to report. Three other laboratories have performed validation exercises in a restricted number of individuals but did not publish any studies using the buccal MN assay (Table I ). The remaining participants in the survey (12 laboratories) had never performed this assay but stated that they were planning to use it in future studies. These latter questionnaires were archived for future evaluation and not considered further in this survey.
All statistics describing the frequency of epidemiological covariates in the HUMN XL database refer to 43 questionnaires returned from laboratories that have performed the buccal MN assay in population studies, while figures on laboratory methods include data from 46 questionnaires. The participants provided a list of publications describing their work in peerreviewed journals using the buccal MN assay .
Type and amount of data available A majority (n 5 34, 79.1%) of the laboratories that reported using the buccal MN assay had also performed the MN assay in lymphocytes. A smaller proportion used the exfoliated cell MN assay with other cell types such as urothelial cells (24%), nasal cells (11%) and cervical smears (13%). Nineteen laboratories (44.2%) reported MN frequency data from buccal cells and lymphocytes in the same individual, creating the opportunity for comparative studies between these two tissues. The reported number of subjects screened with the buccal MN assay has increased dramatically in the last 20 years, rising from the initial sampling of 27 subjects in 1988 to 2292 subjects in 2007. According to the information collected with this survey, data from 15 103 subjects are potentially available for future pooled analyses.
Information available in participants' databases
Based on the responses to the questionnaire, demographic data have been collected in most databases, particularly name/ surname (79%), age (93%), gender (93%) and ethnicity (72%). Unfortunately, the availability of essential data for linkage with cancer registries is limited, i.e. 74% for date of birth and 51% for address. Furthermore, the availability for linkage of individual information could be limited by national regulation concerning the treatment of sensitive data.
Information on medical history and disease status
Family history of cancer is available from 25 laboratories (58.1%), while familial incidence for other diseases has been collected less frequently. Information about current or past diseases (72.0%) or chronic disabilities (67.2%) is also available. Medical records concerning treatment and drug consumption can be used as an important tool for validating medical data and this information was collected in 33 databases (76.7%). The use of recreational drugs was recorded in 20 databases (46.5%).
Information on exposure to tobacco smoke and occupational exposure to genotoxins The impact of these genotoxic exposures on genetic stability was extensively evaluated in the literature for the MN assay in lymphocytes (71, 72) . The pooled approach, which allows analyses of much larger populations than single laboratory studies, revealed novel features concerning the association between MN frequency and the number of cigarettes smoked (73) . In the HUMN XL database, smoking habit is a commonly available covariate, with data on smoking status recorded in 38 laboratories (88.4%). Additionally, most cases (79.1%) have quantitative data on cigarette consumption. Information on exposure to environmental tobacco smoke was collected by 20 laboratories (46.5%). In most databases, data on occupational exposures (86.1%) and exposure to known genotoxic agents (72.1%) are available.
Information on dietary habits and alcohol consumption
Most recent population studies include data concerning the diet. The HUMN XL questionnaire also considered this factor, identifying commonly reported food items. Overall, diet was investigated in 29 laboratories (67.4%). Data on fruit and vegetable consumption are available from 22 laboratories (51.2%). Tea-and coffee-drinking patterns have been reported in 46.5 and 51.2% of laboratories, respectively. Another dietary item that has been frequently assessed is alcohol consumption; this information is available in 34 of 43 laboratories that also S. Bonassi et al. collected population data (79.1%). The measures of the body mass index and vitamin supplementation are variables that are directly linked to diet and were reported in 23.3 and 48.8% of all questionnaires, respectively.
Genetic data
The evaluation of individual genetic and epigenetic profiles is a feature increasingly considered in human population studies. The most frequently acquired parameter is the presence of genetic polymorphisms (nine laboratories corresponding to 20.9 %), while data on biomarkers of genomic damage are available from 18 (41.9%) laboratories.
Information on laboratory methods Buccal cell collection. Several methods for collecting buccal cells have been reported (Figure 1) . The most common method involved a wooden tongue depressor (54%), followed by the use of a toothbrush (20%) and a cytobrush moistened with buffer (11%). All but two laboratories (95.6%) reported sampling buccal cells from the insides of both the left and right cheeks, with only a small proportion (6.5%) reporting further sampling from the sublingual, palatal and pharyngeal areas. Procedures for collecting buccal cells, e.g. how the collection devices were applied to the inside of the cheek, including the number of times the device was rotated against the mucosal surface before transferring cells into a solution and the number of repetitions of the collection procedure within a specified timeframe, were described in more detail in 43% of the questionnaires. Most laboratories (61%) collected only a single sample per individual on a single day and only 37% of the laboratories that collected from both cheeks separately analysed the samples from the left and right cheeks.
Buccal cell and slide preparation. Forty-eight per cent of laboratories reported that collected cells were re-suspended in a buffer and washed to remove debris and bacteria. The washing Eighty per cent of laboratories using Giemsa reported that they used MayGrunwald Giemsa. Fig. 1 . Most commonly adopted buccal cell collection methods in 46 laboratories participating in the HUMN XL survey (some laboratories reported more than one method). x-axis legend: methods, y-axis legend: %.
S. Bonassi et al.
scored by one (53.1%) or two persons (42.9%) and rarely by three scorers (4.1%).
Discussion
This survey has produced a substantial database across a wide range of laboratories and shows that the buccal cell MN assay is far from a standardized procedure, even among those in the same country. In addition, results from published studies suggest that there is a wide range of control values among laboratories and a broad variety of responses in subjects exposed to genotoxic agents (data not shown) (1) . This database will allow us to pool the MN and nuclear anomaly data from a wide range of laboratories and study variability among laboratories, which will contribute to the development of standardized procedures. The availability of this rich source of information will also allow the addressing of fundamental questions regarding demographics, potential genotoxic exposure, dietary and lifestyle variables that may significantly impact on MN frequency in buccal cells. This approach, i.e. the assembly of data from a wide geographical range of laboratories, has already been shown to be effective for the standardization of the cytokinesis-block MN assay in lymphocytes and has helped to define the key variables that need to be controlled in biomonitoring studies for MN induction and the technical conditions that explain most of the interlaboratory variability (4). Furthermore, the creation of a network of laboratories is a basic condition for performing systematic investigations that, together with the results of pooled studies contribute to setting qualitative and quantitative standards. The database assembled in this first phase of the HUMN XL project is highly representative of the current state of the science of the buccal cell MN assay. The geographic distribution of participating laboratories provides a worldwide representation of the techniques used in the various laboratories and the populations that have been screened with the buccal MN assay. The number of subjects available for pooled analyses from this database, i.e. 15 103, is almost twice as high as that included in the previous project on the cytokinesis-block MN assay (4, 79) and it will provide adequate statistical power for testing many hypotheses, including the link between MN frequency in buccal cells and disease risk.
A number of protocol discrepancies that may have been responsible for the interlaboratory variability seen in MN frequency emerged from the evaluation of questionnaires. Technical heterogeneity was evident, beginning with the way the buccal cells were collected. Previous studies have shown that the buccal MN frequency, as well as the frequency of other nuclear anomalies, can vary depending on the degree and vigour of the sampling procedure (55, 79) . This implies that the definition of a standardized approach for buccal cell collection aimed at minimizing variation due to different sampling techniques is a high priority. Ideally, a robotic system that could collect cells uniformly and efficiently by maintaining State of the art survey of the buccal MN assay constant tension against the inside wall of the cheek would be desirable. The observed variation in staining procedures may present a problem because it has been shown that the use of stains that are not DNA specific could produce false-positive or falsenegative results (80, 81) . There is a need to define a reliable and reproducible protocol for staining of buccal cells in a way that minimizes artefacts and is usable under both transmitted light and fluorescence microscopy. The Feulgen-Light green (or Fast green) stain seems to be the most promising given that it is DNA specific and can be used in combination with both common methods of microscopy illumination, i.e. bright field and fluorescence (55, 56) .
Among the potential sources of variability, a major problem is the use of different criteria for identifying and scoring MN and other nuclear anomalies. There is no current consensus on which cell types should be scored (e.g. basal cells only, normal differentiated cells only, both basal and normal differentiated cells or all types of cells including those that are dead or dying). Because MN require nuclear division, it would seem reasonable that scoring should be restricted to the basal cell layer as this is the regenerative layer where nuclear division occurs. On the other hand, expression of MN in these cells could be affected by altered cell division kinetics. Another option is scoring MN in the normal differentiated cells that are the daughter cells of the basal layer and have therefore completed one nuclear division. The counter argument for normal differentiated cells is that they may lose MN during the differentiation process, although no evidence is available to refute or confirm this assumption.
Inclusion of the other end points, measured using a cytome approach, has proved to be a valuable diagnostic tool as was recently shown in studies on Alzheimer's disease, Down syndrome and normal ageing, in which large differences in the frequencies of basal cells, condensed chromatin cells, karyorrhectic cells, binucleated cells and cells with MN were observed (55, 56) . These changes showed distinct differences between the cytome profile of normal ageing and the profile of a premature ageing syndrome. The key buccal cell assay challenges are to define clearly the scoring criteria for each nuclear anomaly and cell type with meticulous graphic detail, as has been achieved previously for the cytokinesis-block micronucleus cytome assay (82) . One good example is the definition of a karyorrhectic cell, which is usually defined as a cell with a broken nucleus. As a matter of fact, this alteration is seen very rarely and has therefore sometimes been interpreted as meaning a cell with a nucleus containing very densely condensed chromatin relative to a condensed chromatin cell (1, 3) . More precise definitions of other cell types such as the nuclear density and the diameter that defines the nucleus of a pyknotic cell and the criteria for defining a nuclear bud (or broken egg) in buccal cells require more attention. Resolving these scoring criteria issues, together with a standardized approach for recording, analysing and reporting data will be an important task for collaborative approaches across laboratories in the future and for interpreting data arising from a variety of laboratories. These criteria have been defined more clearly recently in an attempt to resolve these issues (3) .
The evaluation of the questionnaires clearly showed that the quality of information that can be used for epidemiological studies has increased greatly in recent years. Most laboratories have realized that the availability of host factors or lifestyle parameters of subjects in study groups enhances the scope of the data analyses and allows adjustment for confounding lifestyle factors.
In conclusion, the results of this survey identified the scope, as well as future challenges, for the HUMN XL project. These include (i) Defining the technical and epidemiological key variables that impact on buccal MN frequencies in human populations as measured using current, non-standardized protocols. (ii) Designing the intra-and interlaboratory studies needed to quantify these variables and produce reliable and robust standard protocols for (a) Buccal cell collection and storage (b) Slide preparation and staining (c) Slide scoring and the identification of (1) 
